Joseph K. Belanoff
2020
In 2020, Joseph K. Belanoff earned a total compensation of $5.8M as Chief Executive Officer and President at Corcept Therapeutics, a 16% increase compared to previous year.
Compensation breakdown
| Bonus | $744,000 |
|---|---|
| Option Awards | $4,237,643 |
| Salary | $769,567 |
| Other | $10,892 |
| Total | $5,762,102 |
Belanoff received $4.2M in option awards, accounting for 74% of the total pay in 2020.
Belanoff also received $744K in bonus, $769.6K in salary and $10.9K in other compensation.
Rankings
In 2020, Joseph K. Belanoff's compensation ranked 1,846th out of 13,090 executives tracked by ExecPay. In other words, Belanoff earned more than 85.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,846 out of 13,090 | 86th |
Division Manufacturing | 712 out of 5,621 | 87th |
Major group Chemicals And Allied Products | 257 out of 2,254 | 89th |
Industry group Drugs | 215 out of 1,954 | 89th |
Industry Pharmaceutical Preparations | 153 out of 1,459 | 90th |
Source: SEC filing on April 22, 2021.
Belanoff's colleagues
We found four more compensation records of executives who worked with Joseph K. Belanoff at Corcept Therapeutics in 2020.
News
Corcept Therapeutics CEO Joseph Belanoff's 2021 pay jumps 91% to $11M
April 25, 2022
Corcept Therapeutics CEO Joseph Belanoff's 2020 pay rises 16% to $5.8M
April 22, 2021
Corcept Therapeutics CEO Joseph Belanoff's 2019 pay falls 21% to $5M
April 27, 2020
Corcept Therapeutics CEO Joseph Belanoff's 2018 pay jumps 48% to $6.3M
April 24, 2019